Physician profile
Randall L Busch
NPI 1871522342
$2,425.27
in general payments reported to CMS, 2019-2025
21 companies · $139 in 2025
The $139 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $241 · 2021: $225 · 2022: $556 · 2023: $188 · 2024: $383 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $644.36 | 2021-2025 | Carto 3 |
| Edwards Lifesciences Corporation | $443.48 | 2019-2024 | Hemosphere, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Konect Resilia |
| Baxter Healthcare | $226.86 | 2022 | |
| Amgen INC. | $201.12 | 2019-2020 | |
| Abiomed | $161.91 | 2022-2024 | Impella |
| Cas Medical Systems INC. | $135.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $107.61 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $100.00 | 2019 | |
| Haemonetics Corporation | $65.46 | 2019 | |
| Nuvasive, INC. | $49.29 | 2020 | |
| Abbott Laboratories | $45.54 | 2024 | Navitor |
| Ge Healthcare | $41.53 | 2019-2020 | |
| Olympus America INC. | $33.90 | 2019 | |
| Chiesi USA, INC. | $29.14 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $26.14 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $25.23 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.57 | 2019 | |
| Getinge USA Sales, LLC | $16.07 | 2020 | |
| Boston Scientific Corporation | $14.67 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Busch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.